Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meng-Ju Wu

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Biorxiv : the Preprint Server for Biology|February 20, 2025
Discovery of Chirally-dependent Protein <i>O</i>-2-Hydroxyglutarylation by D2HG and L2HGZheng Zhang, Yi-Kai Liu, Zhuojun Luo, et al.
Molecular Cancer|October 29, 2010
Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signalingMeng-Ju Wu, Chia-Ing Jan, Yeou-Guang Tsay, et al.
Nature Chemistry|March 18, 2026
Discovery of chirally dependent protein modifications by D- and L-2-hydroxyglutaratesZheng Zhang, Yi-Kai Liu, Zhuojun Luo, et al.
JCI Insight|April 9, 2026
Loss of Tumor-Infiltrating Lymphocytes and Poor Response to Immunotherapy in IDH GOF Mutant MelanomaEmma Specht, Lakshmi Pakanati, Meng-Ju Wu, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 12, 2013
Active Component of Antrodia cinnamomea Mycelia Targeting Head and Neck Cancer Initiating Cells through Exaggerated Autophagic Cell DeathChing-Wen Chang, Chien-Chih Chen, Meng-Ju Wu, et al.
Cancer Discovery|April 14, 2022
EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive CholangiocarcinomaQibiao Wu, Yuanli Zhen, Lei Shi, et al.
Cancer Discovery|September 26, 2024
DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingIlaria Gritti, Jinkai Wan, Vajira Weeresekara, et al.
Cancer Discovery|December 1, 2021
Mutant IDH Inhibits IFNγ-TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in CholangiocarcinomaMeng-Ju Wu, Lei Shi, Juan Dubrot, et al.
Annals of the New York Academy of Sciences|March 24, 2023
Immunometabolism at the crossroads of obesity and cancer-a Keystone Symposia reportJennifer Cable, Jeffrey C Rathmell, Erika L Pearce, et al.
Nature Genetics|June 9, 2026
Inflammatory cytokines induce new cancer dependenciesCollins K Cheruiyot, Sarah Y Kim, Juan Dubrot, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|February 20, 2025
Discovery of Chirally-dependent Protein <i>O</i>-2-Hydroxyglutarylation by D2HG and L2HGZheng Zhang, Yi-Kai Liu, Zhuojun Luo, et al.
Molecular Cancer|October 29, 2010
Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signalingMeng-Ju Wu, Chia-Ing Jan, Yeou-Guang Tsay, et al.
Nature Chemistry|March 18, 2026
Discovery of chirally dependent protein modifications by D- and L-2-hydroxyglutaratesZheng Zhang, Yi-Kai Liu, Zhuojun Luo, et al.
JCI Insight|April 9, 2026
Loss of Tumor-Infiltrating Lymphocytes and Poor Response to Immunotherapy in IDH GOF Mutant MelanomaEmma Specht, Lakshmi Pakanati, Meng-Ju Wu, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 12, 2013
Active Component of Antrodia cinnamomea Mycelia Targeting Head and Neck Cancer Initiating Cells through Exaggerated Autophagic Cell DeathChing-Wen Chang, Chien-Chih Chen, Meng-Ju Wu, et al.
Cancer Discovery|April 14, 2022
EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive CholangiocarcinomaQibiao Wu, Yuanli Zhen, Lei Shi, et al.
Cancer Discovery|September 26, 2024
DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingIlaria Gritti, Jinkai Wan, Vajira Weeresekara, et al.
Cancer Discovery|December 1, 2021
Mutant IDH Inhibits IFNγ-TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in CholangiocarcinomaMeng-Ju Wu, Lei Shi, Juan Dubrot, et al.
Annals of the New York Academy of Sciences|March 24, 2023
Immunometabolism at the crossroads of obesity and cancer-a Keystone Symposia reportJennifer Cable, Jeffrey C Rathmell, Erika L Pearce, et al.
Nature Genetics|June 9, 2026
Inflammatory cytokines induce new cancer dependenciesCollins K Cheruiyot, Sarah Y Kim, Juan Dubrot, et al.
Pageof 4